A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer
Eo Jin Kim, Yong-Hee Cho, Dong Ha Kim, Dae-Hyun Ko, Eun-Ju Do, Sang-Yeob Kim, Yong Man Kim, Jae Seob Jung, Yoonmi Kang, Wonjun Ji, Myeong Geun Choi, Jae Cheol Lee, Jin Kyung Rho, Chang-Min Choi
Cancer Res Treat. 2022;54(4):1005-1016.   Published online 2021 Dec 3     DOI: https://doi.org/10.4143/crt.2021.986
Citations to this article as recorded by Crossref logo
Natural killer cells: the next wave in cancer immunotherapy
Xin Chen, Lei Jiang, Xuesong Liu
Frontiers in Immunology.2022;[Epub]     CrossRef